PHILADELPHIA and VANCOUVER, British Columbia, Aug. 05, 2025 (GLOBE NEWSWIRE) -- BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXW, BCTXZ) (TSX: BCT) (“BriaCell” or the “Company”), a clinical-stage biotechnology company that develops novel immunotherapies to transform cancer care announced today that the Company’s board of directors has approved the consolidation (the “Consolidation”) of the Company’s issued and outstanding common shares (the “Common Shares”) on the basis of one (1) post-Consolidation Common Share for every ten (10) pre-Consolidation Common Shares. The Consolidation is being implemented to ensure that the Company continues to comply with the listing requirements of The Nasdaq Capital Market (the “Nasdaq”).
Is Increased Use of PGT-A Always Better? Experts Call for Evidence-Based Use of Mosaic EmbryosChoosing the Right PGT-A Platform: NUWA Fertility and Global Experts Unite...
CALGARY, AB, Aug. 5, 2025 /PRNewswire/ - Frontera Energy Corporation (TSX: FEC) ("Frontera" or the "Company") announced today that the Company agreed to divest its...
SURPRISE, Ariz., Aug. 5, 2025 /PRNewswire/ -- SenesTech, Inc. (NASDAQ: SNES, "SenesTech" or the "Company"), a leader in fertility control for managing animal pest...
Caribbean Utilities Company, Ltd. is listed for trading in United States dollars on the Toronto Stock Exchange under the trading symbol "CUP.U".
GRAND CAYMAN,...
Next-Generation DPU Delivers High-Performance Offloads for Storage, Security, and AI at 400G
SUNNYVALE, Calif., Aug. 5, 2025 /PRNewswire/ -- Chelsio Communications, Inc., a leading provider of...
Record second quarter Adjusted EBITDA1 of $508 million
Demonstrates strength and run rate potential of Parkland's diversified business
Advancing the Sunoco Transaction2
CALGARY, AB, Aug. 5, 2025...
Record second quarter Adjusted EBITDA1 of $508 million
Demonstrates strength and run rate potential of Parkland's diversified business
Advancing the Sunoco Transaction2
CALGARY, AB, Aug. 5, 2025...
Record second quarter Adjusted EBITDA1 of $508 million
Demonstrates strength and run rate potential of Parkland's diversified business
Advancing the Sunoco Transaction2
CALGARY, AB, Aug. 5, 2025...
TSX:GWO
Great-West Lifeco Inc.'s Quarterly Report to Shareholders for the second quarter of 2025, including its Management's Discussion and Analysis (MD&A) and consolidated financial statements...